» Articles » PMID: 30941757

Melanoma Risk Stratification of Individuals with a High-risk Naevus Phenotype - A Pilot Study

Overview
Specialty Dermatology
Date 2019 Apr 4
PMID 30941757
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background/objectives: High a naevus counts and atypical naevi are risk factors for cutaneous melanoma. However, many individuals with a high-risk naevus phenotype do not develop melanoma. In this study, we describe the clinical and dermoscopic attributes of naevi associated with melanoma in a high-risk naevus phenotype population.

Methods: This single-centre, hospital-based case-control study included 54 prospectively enrolled adult patients ≥18 years old with a high-risk naevus phenotype (18 cases with a history of melanoma and 36 age- and gender-matched controls without a history of melanoma). We analysed clinical and dermoscopic images of the 20 largest naevi for each participant.

Results: Cases had a higher mean age than controls (48.2 vs. 39.1 years, P = 0.007) but there was no difference in the male-to-female ratio between groups. Nearly, all participants (97%) were Fitzpatrick skin type II or III. Naevi in cases were more likely to be truncal, (72.6% vs. 53.6%, P = 0.01), particularly anterior truncal, (29.2% vs. 14.4%, P < 0.001) and larger than 8 mm (17.4% vs. 7.8%%, P = 0.01) compared to controls. CASH score of naevi did not differ between groups. Naevi in cases were more likely to have a multicomponent dermoscopic pattern than in controls (18.4% vs. 12.6%, P = 0.02).

Conclusion: Larger naevi, truncal naevi, and naevi, with a multicomponent dermoscopic pattern may be risk factors for melanoma among individuals with a high-risk naevus phenotype. Further studies are needed to validate these findings.

Citing Articles

The Role of Digital Dermoscopy and Follow-Up in the Detection of Amelanotic/Hypomelanotic Melanoma in a Group of High-Risk Patients-Is It Useful?.

Jurakic Toncic R, Vasari L, Stulhofer Buzina D, Ledic Drvar D, Petkovic M, Ceovic R Life (Basel). 2024; 14(9).

PMID: 39337982 PMC: 11432978. DOI: 10.3390/life14091200.


Multiple Primary Melanoma: A Five-Year Prospective Single-Center Follow-Up Study of Two MC1R R/R Genotype Carriers.

Sortino A, Soares de Sa B, Martins M, Bertolli E, Paula R, Pinto C Life (Basel). 2023; 13(10).

PMID: 37895483 PMC: 10608495. DOI: 10.3390/life13102102.


Exploring Small-Diameter Melanomas: A Retrospective Study on Clinical and Dermoscopic Features.

Hunziker M, Abdalla B, Brandao F, Meneghello L, Hunnicutt J, Di Giacomo T Life (Basel). 2023; 13(9).

PMID: 37763310 PMC: 10533118. DOI: 10.3390/life13091907.

References
1.
Naldi L, Lorenzo Imberti G, Parazzini F, Gallus S, La Vecchia C . Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer. 2000; 88(12):2703-10. DOI: 10.1002/1097-0142(20000615)88:12<2703::aid-cncr8>3.0.co;2-q. View

2.
Gachon J, Beaulieu P, Sei J, Gouvernet J, Claudel J, Lemaitre M . First prospective study of the recognition process of melanoma in dermatological practice. Arch Dermatol. 2005; 141(4):434-8. DOI: 10.1001/archderm.141.4.434. View

3.
Adameyko I, Lallemend F, Aquino J, Pereira J, Topilko P, Muller T . Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell. 2009; 139(2):366-79. DOI: 10.1016/j.cell.2009.07.049. View

4.
Gandini S, Sera F, Cattaruzza M, Pasquini P, Abeni D, Boyle P . Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2004; 41(1):28-44. DOI: 10.1016/j.ejca.2004.10.015. View

5.
Moloney F, Guitera P, Coates E, Haass N, Ho K, Khoury R . Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatol. 2014; 150(8):819-27. DOI: 10.1001/jamadermatol.2014.514. View